Studies demonstrating faecal shedding of SARS-CoV-2
| Study | Region | Patients with positive stool/rectal sample (n) | Duration of positive infection (in days) | Patients with positive stool/rectal samples after negative respiratory samples (n) |
| Adult studies | ||||
| Kujawski et al 13 | USA | 7/12 (58.3%) | 1–12 | 1/7 (14.3%) |
| Joukar et al 15 | Guilian province, Iran | 6/100 (6%) | 8–42 | NA |
| Lin et al 17 | Guangzhou, China | 46/217 (21.2%) | 3–18 | 30/46 (65.2%) |
| Lo et al 21 | Macau, China | 9/9 (100%) | 1–18 | 1/9 (11.1%) |
| Zhao et al 22 | China | 80/401 (19.95%) | NA | NA |
| Chen et al 23 | Wuhan, China | 28/42 (66.67%) | NA | 18/28 (64.29%) |
| Paediatric studies | ||||
| Xu et al 16 | Gangzhou, China | 8/10 (80%) | 3–28 | 8/8 (100%) |
| Liu et al 18 | Shanghai, China | 8/9 (89%) | 28–66 | 8/8 (100%) |
| Huang et al 19 | Zhejiang, China | 11/16 (69%) | NA | NA |
| Han et al 20 | Wuhan,China | 12/22 (54.5%) | 80% positive >3 weeks | NA |